Royal Bank of Canada
PRNB

Royal Bank of Canada’s Principia Biopharma Inc. Common Stock PRNB Stock Holding History

Royal Bank of Canada’s Portfolio PRNB Stock Details PRNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-31
Closed -$2K – 7208
2020
Q2 		$2K Sell
31
-66
-68% -$4.08K ﹤0.01% 6361
2020
Q1 		$6K Sell
97
-266
-73% -$15.5K ﹤0.01% 6013
2019
Q4 		$20K Buy
+363
New +$13.6K ﹤0.01% 5862
2019
Q2 		– Sell
-500
Closed -$17K – 7366
2019
Q1 		$17K Buy
+500
New +$15.9K ﹤0.01% 5740

Other funds holding PRNB

Ohio Public Employees Retirement System (OPERS)
Ohio Public Employees Retirement System (OPERS) Columbus, Ohio $34B AUM 40.73% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $171B AUM 85% 1-Year Est. Return
Skandinaviska Enskilda Banken (SEB)
Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $2.66B AUM 26.2% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Public Employees Retirement Association of Colorado
Public Employees Retirement Association of Colorado Denver, Colorado $28.9B AUM 44.1% 1-Year Est. Return
AB
Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ADL
Asset Dedication LLC San Francisco, California $1.59B AUM 26.56% 1-Year Est. Return

Royal Bank of Canada's PRNB Position: Q3 2020 in Review

Royal Bank of Canada sold out of Principia Biopharma Inc. Common Stock (PRNB) in Q3 2020, closing a stake of 31 shares — an estimated $2K sold.

Royal Bank of Canada first reported a position in PRNB in Q1 2019 and held it in 4 quarters. The position peaked at $20K in Q4 2019. 9 funds tracked by Wall St. Rank hold PRNB as of Q3 2020.

  • Royal Bank of Canada reported no remaining Principia Biopharma Inc. Common Stock position as of Q3 2020 after selling out during the quarter.
  • Royal Bank of Canada sold 31 Principia Biopharma Inc. Common Stock shares in Q3 2020, an estimated $2K.
  • Royal Bank of Canada first reported a position in Principia Biopharma Inc. Common Stock in Q1 2019 and held it in 4 quarters.
  • Royal Bank of Canada's Principia Biopharma Inc. Common Stock position peaked at $20K in Q4 2019.
  • 9 funds tracked by Wall St. Rank held Principia Biopharma Inc. Common Stock as of Q3 2020.

Based on Royal Bank of Canada's 13F filing for Q3 2020, filed 16 Nov 2020.